Astellas Exercises Option to Acquire Potenza Therapeutics
By Michelle Liu
Pharma Deals Review: Vol 2018 Issue 12 (Table of Contents)
Published: 20 Dec-2018
DOI: 10.3833/pdr.v2018.i12.2386 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Exercising an option as part of a 2015 collaboration, Astellas Pharma has acquired Potenza Therapeutics in a deal worth potentially up to US$404...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS